Patent · US Active

Modified native beta-ketoacyl-ACP synthases and engineered microorganisms

US9512447B2 · kind B2 · utility

1Cited by

29References

31Claims

0Family size

Assignee

Codexis, Inc. · US

Inventors

Smita Shankar · Bengaluru, IN
Louis Clark · San Francisco, US
Robert Osborne · North Tonawanda, US
Jonathan Vroom · South San Francisco, US
Fernando Valle · Palo Alto, US
Catherine M. Cho · Davis, US

Key dates

Filing date	Dec 4, 2013
Grant date	Dec 6, 2016
Priority date	—
Expiry date	Dec 4, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically engineered cells and microorganisms are provided that produce fatty alcohols and fatty acids. In particular, engineered microbial cells comprise a modified native gene having β-ketoacyl-acp synthase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.